Long-term follow-up of treatment-naïve HBeAg-negative patients with chronic hepatitis B.

Yusuf Emre Ozdemir Meryem Sahin Ozdemir Osman Faruk Bayramlar Serkan Sürme Sibel Yıldız Kaya Ridvan Karaali I Lker İnanç Balkan Bilgül Mete Neşe Saltoğlu Ömer Fehmi Tabak

Published in: Irish journal of medical science (2022)

CVR was achieved at similar rates with all four antiviral agents, while younger age (≤ 40) and low baseline viral load were the main factors for virological response. However, drug resistance and virological breakthrough in the LAM group and side effects in the LdT group were detected during the long-term follow-up. Moreover, HBsAg seroclearance was achieved at very low rates with oral antiviral agents.

Keyphrases

hepatitis b virus
hiv infected
antiretroviral therapy
hiv infected patients
replacement therapy